New Zealand imaging provider to use AI for prostate cancer detection

Michael Walter | | Radiology Business | Artificial Intelligence
Cheryl Petersilge, MD, MBA, with the department of regional radiology at the Cleveland Clinic, examined enterprise imaging—and how radiologists must integrate and collaborate with other departments. Her clinical perspective clinical perspective was published online in the October issue of the American Journal of Roentgenology.

Mercy Radiology, a New Zealand-based imaging provider, has plans to use artificial intelligence (AI) algorithms to help with the detection of prostate cancer.

According to a new report from Newshub, Mercy Radiology is looking to begin its trial run with AI algorithms “in the next few months.” The provider’s plan is for the AI to work in the background while radiologists work like normal.

“The radiologist will report the scan as usual, but the algorithm will be running in parallel, looking at the image data that is captured and assessing whether there is something that needs to be reported or not,” Dr. Lloyd McCann, CEO of Mercy Radiology, told Newshub in an interview.  

To read the full story, click the link below.

NZ radiology centres to trial AI diagnosis

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Startup aiming to automate 90% of imaging workflows, creating an ‘AI radiology resident,’ raises $23M
ACR, top health systems form collaborative to help radiologists assess AI solutions
Radiology AI firm Mediaire raises nearly $12.7M in financing
RadNet stock surges 20% to all-time high following news of GE HealthCare partnership
Radiology AI vendor Volpara Health inks $7M Department of Defense contract
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.